The short answer
The Therapeutic Goods Amendment Bill 2025: a minor technical fix to medicines regulation explained
If passed, the Therapeutic Goods Amendment Bill 2025 is a government bill that makes a single minor technical amendment to the Therapeutic Goods Act 1989. The bill's official summary describes it in just one phrase: 'makes a minor technical amendment.' It was introduced in the House of Representatives on 22 July 2025 under the Prime Minister's portfolio and is before the House.
This is a federal system guide. State constitutions, parliaments and local-government laws can allocate comparable functions differently.
The useful question is not only “what is the rule?” but also “who administers it, which document controls it, and when might it change?” That distinction prevents an accurate general explanation from becoming wrong advice in a particular election, chamber or policy setting.
Evidence review
What the bill proposes
The Therapeutic Goods Amendment Bill 2025 is notable for being one of the briefest bills introduced in the 48th Parliament. The official summary on the Parliament of Australia website states simply that it 'amends the Therapeutic Goods Act 1989 to make a minor technical amendment.' While the exact nature of the technical amendment is not expanded upon in the summary, it is described in the Explanatory Memorandum which accompanies the bill.
Technical amendment bills are a routine part of legislative practice. They typically fix drafting errors, correct cross-references between sections, update outdated terminology, or align provisions with other legislative changes. They do not introduce new policy, change regulatory standards, or alter the rights or obligations of regulated entities in any substantive way.
Evidence review
The Therapeutic Goods Act 1989
The Therapeutic Goods Act 1989 is the principal Commonwealth legislation governing medicines, medical devices, biological products, and other therapeutic goods in Australia. It establishes the Therapeutic Goods Administration (TGA) as the national regulator and sets out the framework for product registration, listing, manufacturing licensing, advertising, and post-market monitoring.
The Act has been amended many times since its enactment — often for major policy changes such as the introduction of the Australian Register of Therapeutic Goods (ARTG), new regulatory pathways for complementary medicines, or reforms to medical device regulation. Technical amendment bills like this one sit at the other end of the spectrum: they keep the statute book accurate without changing the regulatory framework.
Evidence review
Parliamentary status and portfolio
The bill was introduced in the House of Representatives on 22 July 2025 and is currently listed as 'Before House of Representatives.' It is a government bill — meaning it was introduced by a minister on behalf of the government, rather than by a private member or senator. The bill falls under the Prime Minister's portfolio, which includes responsibility for the Therapeutic Goods Administration through the Department of Health and Aged Care.
Government bills typically receive priority in parliamentary scheduling, and technical amendment bills of this nature generally attract bipartisan support and pass without significant debate. As of July 2026, the bill had not yet been debated or voted on in the House.
Evidence review
Why technical amendment bills matter
While a 'minor technical amendment' may sound insignificant, such bills serve an important function in maintaining the integrity of the Commonwealth statute book. Over time, cross-references can break when other Acts are amended, provisions can become inconsistent with newer legislation, and drafting anomalies can create legal uncertainty. Technical amendment bills ensure that the laws administered by regulators and relied upon by industry are accurate and workable.
These bills are sometimes grouped into omnibus or 'statute law revision' bills that correct multiple Acts at once. That this amendment is a standalone bill suggests it addresses a specific issue that needed to be resolved independently of other technical corrections.
Evidence review
What the bill does not do
Readers should be clear that this bill does not change the regulatory standards for therapeutic goods in Australia. It does not introduce new requirements for medicines, medical devices, or other therapeutic products. It does not alter the powers of the TGA or the Secretary of the Department of Health. And it does not affect any products currently on the Australian market or under review by the TGA. The bill is, by its own description and by government characterisation, a minor technical correction.
Common questions
Before you rely on the answer
What exactly does the bill change?
The bill makes a minor technical amendment to the Therapeutic Goods Act 1989. The precise nature of the amendment is detailed in the Explanatory Memorandum. Based on the official summary and the bill's characterisation as a technical fix, it is a drafting or cross-referencing correction rather than a policy change.
What is the Therapeutic Goods Act 1989?
It is the principal Commonwealth Act that regulates therapeutic goods in Australia, including prescription medicines, over-the-counter medicines, medical devices, biological products, and complementary medicines. The Act establishes the Therapeutic Goods Administration and the Australian Register of Therapeutic Goods.
Why is this bill under the Prime Minister's portfolio?
The Therapeutic Goods Administration sits within the Department of Health and Aged Care, which is part of the Prime Minister's portfolio responsibilities. In Australian government arrangements, the Prime Minister's portfolio can include a range of agencies and functions beyond the Department of the Prime Minister and Cabinet.
Has this bill become law?
No. As of July 2026 the bill is before the House of Representatives. It was introduced on 22 July 2025 and had not yet been debated or voted on. Technical amendment bills of this nature typically pass with little debate once scheduled.
Source spine
Primary material used for this guide
- Therapeutic Goods Amendment Bill 2025 — APH Bill Page — checked 2026-07-17
- Bill text (ParlInfo) — checked 2026-07-17
- Explanatory Memorandum (ParlInfo) — checked 2026-07-17
Review trigger: Bill is debated, amended, passed by either house, or lapses at end of Parliament.
Archive note: This article reviews the bill as introduced on 22 July 2025. The bill had not been debated as of the review date. The article relies on the official bill summary and does not reproduce the Explanatory Memorandum in full. Check the Parliament of Australia Bills page for current status.
Primary links are provided without affiliate or tracking parameters. Confirm that the source still applies to the bill, sitting date, jurisdiction or reporting period before relying on it.